Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Head and Neck Cancers
•
Radiation Oncology
How would you treat a head and neck patient who had definitive chemoradiation who develops an isolated mediastinal lymph node recurrence?
Do you offer definitive treatment?
Systemic therapy alone since it's metastatic?
Answer from: Radiation Oncologist at Academic Institution
45 Gy/25 fx to mediastinum and boost to positive node to 65 to 70 Gy.
Comments
Radiation Oncologist at Karmanos Cancer Institute - McLaren Proton Therapy Center
I agree with Dr. @William M. Mendenhall, treat for...
5546
Sign In
or
Register
to read more
11759
Related Questions
What's the role of contralateral neck re-irradiation in the post-op setting for someone with a remote history of head and neck cancer who underwent definitive RT with elective dose to the bilateral neck now with a new primary s/p surgery with ipsilateral neck dissection requiring post op chemo radiation for bony involvement and ENE?
What is the role of adjuvant RT for metastatic RCC to the thyroid resected with high-risk features?
What is the role of radiation therapy for Kimura's disease of the parotid and neck?
How would you counsel a patient concerned about receiving IMRT rather than IMPT for oropharyngeal cancer?
Is there a scenario in which you would consider observation for T4a SCC involving the mandible?
What are your top takeaways in Head & Neck Cancers from ASCO 2025?
How would the updated results of ECOG 3311 influence your adjuvant RT recommendations for HPV+ OPSCC?
What is your recommendation for patients who are on weight loss medications like GLP-1-based therapies while receiving chemoradiation for head and neck cancer?
What is the role for chemo immunotherapy in the up front setting in non-metastatic head & neck cancer outside of clinical trials?
In p16-positive oropharyngeal squamous cell carcinoma, when induction therapy is considered before definitive chemoradiation, how do you choose between a traditional TPF regimen and carboplatin/paclitaxel/pembrolizumab?
I agree with Dr. @William M. Mendenhall, treat for...